ECHO Trial Commentary

FP ECHO Trial Commentary The long-awaited results of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, a rigorous, three-year clinical study designed to resolve if using Depo Provera (DMPA-IM) increases women and adolescent girls’ risk of HIV, are...

A Roadmap for Results: Understanding the ECHO Trial Findings

A Roadmap for Results: Understanding the ECHO Trial Findings Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study were released at SA AIDS in Durban, South Africa, on Thursday, June 13th. The ECHO team is committed to sharing these results...

A Roadmap for Results: Supporting Countries to Plan for the ECHO Trial Results

A Roadmap for Results: Supporting Countries to Plan for the ECHO Trial Results This webinar was hosted by AVAC, Breakthrough ACTION, and FP2020 to discuss a new Country Roadmap that provides templates that countries can use before, during, and after the release of...

Préparation à l’étude ECHO Ressources

Préparation à l’étude ECHO Ressources Préparation à l’étude ECHO Ressources Ressources qui vous aideront à vous préparer aux résultats de l’étude ECHO (Evidence for Contraceptive Options and HIV Outcomes). Bon nombre de ces ressources peuvent être adaptées...

Webinar: Hormonal Contraception and HIV Risk: Understanding the ECHO Trial

Webinar: Hormonal Contraception and HIV Risk: Understanding the ECHO Trial The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the...